AFFIMED Trademark

Trademark Overview


On Friday, September 16, 2022, a trademark application was filed for AFFIMED with the United States Patent and Trademark Office. The USPTO has given the AFFIMED trademark a serial number of 97594404. The federal status of this trademark filing is REGISTERED as of Tuesday, January 23, 2024. This trademark is owned by Affimed GmbH. The AFFIMED trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and veterinary preparations, namely, pharmaceutical and veterinary preparations used for tumour treatment, cancer treatment, and immunotherapy purposes; biological and biochemical preparations in form of antibodies, antibody derivatives, binding proteins and peptides for medical or veterinary purposes, all used for tumour treatment, cancer treatment, and immunotherapy purposes; biological and biochemical preparations for medical or veterinary purposes and in the form of bifunctional or multifunctional proteins with binding affinity to immune cells, in particular with binding affinity to T cells and natural killer (NK) cells, in particular for the subsequent targeting of cancer cells; biological and biochemical preparations for medical or veterinary purposes and for diagnostic and therapeutic use, in particular in form of antibodies, antibody derivatives, binding proteins and peptides, all used for treatment of cancer, treatment of tumours, and immunotherapy purposes; bio...

Biological and biochemical preparations, in particular in form of antibodies, antibody derivatives, binding proteins and peptides for scientific laboratory and scientific experimentation purposes, in particular for conducting experimental assays, all of the foregoing other than for medical or veterinary purposes

Scientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research and design in the nature of new product design, all in the field of immunotherapy, in particular in the field of immuno-oncology; scientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research and design in the nature of new product design, all in the field of virology; scientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research and design in the nature of new product design and engineering design, all in the field of antiinfectives; scientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research, and design in the nature of new product design, all in the f...
affimed

General Information


Serial Number97594404
Word MarkAFFIMED
Filing DateFriday, September 16, 2022
Status700 - REGISTERED
Status DateTuesday, January 23, 2024
Registration Number7283748
Registration DateTuesday, January 23, 2024
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 7, 2023

Trademark Statements


Description of MarkThe mark consists of the stylized term "AFFIMED" with the letters "AFFI" in teal and the letters "MED" in pink and with a stylized image of a cell inside of a teal single line circle to the left of the letter "A" and with two short teal lines extending from the lower right edge of the circle. The cell is colored in various shades of pink and in the interior of the cell is an oval colored in a dark shade of pink with a white outline. The remaining color white indicates transparent area and is not part of the mark.
Goods and ServicesPharmaceutical and veterinary preparations, namely, pharmaceutical and veterinary preparations used for tumour treatment, cancer treatment, and immunotherapy purposes; biological and biochemical preparations in form of antibodies, antibody derivatives, binding proteins and peptides for medical or veterinary purposes, all used for tumour treatment, cancer treatment, and immunotherapy purposes; biological and biochemical preparations for medical or veterinary purposes and in the form of bifunctional or multifunctional proteins with binding affinity to immune cells, in particular with binding affinity to T cells and natural killer (NK) cells, in particular for the subsequent targeting of cancer cells; biological and biochemical preparations for medical or veterinary purposes and for diagnostic and therapeutic use, in particular in form of antibodies, antibody derivatives, binding proteins and peptides, all used for treatment of cancer, treatment of tumours, and immunotherapy purposes; biological and biochemical preparations in form of antibodies, antibody derivatives, binding proteins and peptides for use within the framework of experimental and medical or veterinary assays, all used for treatment of cancer, treatment of tumours, and immunotherapy purposes
Pseudo MarkAFFI MED
Indication of Colors claimedThe color(s) teal, pink and white is/are claimed as a feature of the mark.
Goods and ServicesBiological and biochemical preparations, in particular in form of antibodies, antibody derivatives, binding proteins and peptides for scientific laboratory and scientific experimentation purposes, in particular for conducting experimental assays, all of the foregoing other than for medical or veterinary purposes
Goods and ServicesScientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research and design in the nature of new product design, all in the field of immunotherapy, in particular in the field of immuno-oncology; scientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research and design in the nature of new product design, all in the field of virology; scientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research and design in the nature of new product design and engineering design, all in the field of antiinfectives; scientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research, and design in the nature of new product design, all in the field of neurodegenerative diseases; scientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research and design in the nature of new product design, all in the field of autoimmune diseases; in particular all of the aforesaid services related to the use of antibodies, antibody derivatives, binding proteins and peptides; scientific and technological services in the nature of scientific and technological research, research in the nature of medical and pharmaceutical research and design in the nature of new product design, all in the field of immunotherapy by means of activating or modulating innate and adaptive immunity, in particular in the field of immune-oncology; industrial analysis and research services, namely, industrial research in the field of pharmaceuticals

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, October 3, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 3, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 3, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAffimed GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressMannheim 68165

Party NameAffimed GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressMannheim 68165

Party NameAffimed GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressMannheim 68165

Trademark Events


Event DateEvent Description
Tuesday, January 23, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 23, 2024REGISTERED-PRINCIPAL REGISTER
Thursday, January 4, 2024ASSIGNED TO EXAMINER
Tuesday, November 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 7, 2023PUBLISHED FOR OPPOSITION
Wednesday, October 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 6, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 6, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 2, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 3, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 3, 2023NON-FINAL ACTION E-MAILED
Monday, July 3, 2023NON-FINAL ACTION WRITTEN
Wednesday, June 28, 2023ASSIGNED TO EXAMINER
Tuesday, October 4, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, October 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 20, 2022NEW APPLICATION ENTERED